Cover
Cover - shares | 3 Months Ended | |
Mar. 29, 2024 | Apr. 30, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 29, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-36341 | |
Entity Registrant Name | V2X, Inc. | |
Entity Incorporation, State or Country Code | IN | |
Entity Tax Identification Number | 38-3924636 | |
Entity Address, Address Line One | 7901 Jones Branch Drive, Suite 700, | |
Entity Address, City or Town | McLean | |
Entity Address, State or Province | VA | |
Entity Address, Postal Zip Code | 22102 | |
City Area Code | (571) | |
Local Phone Number | 481-2000 | |
Title of 12(b) Security | Common Stock, Par Value $0.01 Per Share | |
Trading Symbol | VVX | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 31,459,020 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Entity Central Index Key | 0001601548 | |
Current Fiscal Year End Date | --12-31 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 1,010,564 | $ 943,460 |
Cost of revenue | 940,290 | 864,630 |
Selling, general, and administrative expenses | 39,943 | 48,251 |
Operating income | 30,331 | 30,579 |
Loss on extinguishment of debt | 0 | (22,052) |
Interest expense, net | (27,574) | (31,744) |
Other expense, net | (1,633) | 0 |
Income (loss) from operations before income taxes | 1,124 | (23,217) |
Income tax benefit | (20) | (5,737) |
Net income (loss) | $ 1,144 | $ (17,480) |
Earnings (loss) per share | ||
Basic (in dollars per share) | $ 0.04 | $ (0.57) |
Diluted (in dollars per share) | $ 0.04 | $ (0.57) |
Weighted average common shares outstanding - basic (in shares) | 31,351 | 30,927 |
Weighted average common shares outstanding - basic (in shares) | 31,794 | 30,927 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Statement of Comprehensive Income [Abstract] | ||
Net income (loss) | $ 1,144 | $ (17,480) |
Changes in derivative instruments: | ||
Net change in fair value of interest rate swaps | 4,921 | (2,347) |
Tax benefit | 430 | 148 |
Net change in derivative instruments | 5,351 | (2,199) |
Foreign currency translation adjustments, net of tax | (2,843) | 1,806 |
Other comprehensive income (loss), net of tax | 2,508 | (393) |
Total comprehensive income (loss) | $ 3,652 | $ (17,873) |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 29, 2024 | Dec. 31, 2023 |
Current assets | ||
Cash, cash equivalents and restricted cash | $ 35,658 | $ 72,651 |
Receivables | 788,490 | 705,995 |
Prepaid expenses and other current assets | 129,427 | 96,223 |
Total current assets | 953,575 | 874,869 |
Property, plant, and equipment, net | 93,362 | 85,429 |
Goodwill | 1,648,298 | 1,656,926 |
Intangible assets, net | 389,448 | 407,530 |
Right-of-use assets | 37,629 | 41,215 |
Other non-current assets | 17,379 | 15,931 |
Total non-current assets | 2,186,116 | 2,207,031 |
Total Assets | 3,139,691 | 3,081,900 |
Current liabilities | ||
Accounts payable | 430,600 | 453,052 |
Compensation and other employee benefits | 139,349 | 158,088 |
Short-term debt | 15,361 | 15,361 |
Other accrued liabilities | 267,425 | 213,700 |
Total current liabilities | 852,735 | 840,201 |
Long-term debt, net | 1,154,345 | 1,100,269 |
Deferred tax liabilities | 13,698 | 11,763 |
Operating lease liabilities | 32,419 | 34,691 |
Other non-current liabilities | 92,758 | 104,176 |
Total non-current liabilities | 1,293,220 | 1,250,899 |
Total liabilities | 2,145,955 | 2,091,100 |
Commitments and contingencies (Note 7) | ||
Shareholders' Equity | ||
Preferred stock; $0.01 par value; 10,000,000 shares authorized; No shares issued and outstanding | 0 | 0 |
Common stock; $0.01 par value; 100,000,000 shares authorized; 31,452,806 and 31,191,628 shares issued and outstanding as of March 29, 2024 and December 31, 2023, respectively | 315 | 312 |
Additional paid in capital | 761,605 | 762,324 |
Retained earnings | 231,995 | 230,851 |
Accumulated other comprehensive loss | (179) | (2,687) |
Total shareholders' equity | 993,736 | 990,800 |
Total Liabilities and Shareholders' Equity | $ 3,139,691 | $ 3,081,900 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Mar. 29, 2024 | Dec. 31, 2023 |
Shareholders' Equity | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 31,452,806 | 31,191,628 |
Common stock, shares outstanding (in shares) | 31,452,806 | 31,191,628 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Operating activities | ||
Net income (loss) | $ 1,144 | $ (17,480) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Depreciation expense | 6,243 | 5,412 |
Amortization of intangible assets | 22,539 | 22,606 |
Loss on disposal of property, plant, and equipment | 8 | 31 |
Stock-based compensation | 5,149 | 12,872 |
Deferred taxes | (262) | (6,034) |
Amortization of debt issuance costs | 2,160 | 2,513 |
Loss on extinguishment of debt | 0 | 22,052 |
Changes in assets and liabilities: | ||
Receivables | (55,363) | (30,649) |
Other assets | (23,522) | (9,778) |
Accounts payable | (33,715) | (4,115) |
Compensation and other employee benefits | (18,607) | (24,182) |
Other liabilities | 37,000 | (11,740) |
Net cash used in operating activities | (57,226) | (38,492) |
Investing activities | ||
Purchases of capital assets | (7,775) | (9,076) |
Proceeds from the disposition of assets | 5 | 0 |
Acquisitions of businesses | (16,939) | 0 |
Net cash used in investing activities | (24,709) | (9,076) |
Financing activities | ||
Proceeds from issuance of long-term debt | 0 | 250,000 |
Repayments of long-term debt | (3,840) | (421,013) |
Proceeds from revolver | 375,250 | 348,750 |
Repayments of revolver | (319,250) | (163,750) |
Proceeds from stock awards and stock options | 3 | 5 |
Payment of debt issuance costs | 0 | (7,507) |
Prepayment premium on early redemption of debt | 0 | (1,600) |
Payments of employee withholding taxes on share-based compensation | (5,702) | (12,806) |
Net cash provided by (used in) financing activities | 46,461 | (7,921) |
Exchange rate effect on cash | (1,519) | 1,567 |
Net change in cash, cash equivalents and restricted cash | (36,993) | (53,922) |
Cash, cash equivalents and restricted cash - beginning of period | 72,651 | 116,067 |
Cash, cash equivalents and restricted cash - end of period | 35,658 | 62,145 |
Supplemental disclosure of cash flow information: | ||
Interest paid | 27,125 | 29,066 |
Income taxes paid | 1,014 | 300 |
Purchase of capital assets on account | $ 410 | $ 494 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Changes to Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock Issued | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) Income |
Balance (in shares) at Dec. 31, 2022 | 30,470 | ||||
Balance at Dec. 31, 2022 | $ 997,079 | $ 305 | $ 748,877 | $ 253,424 | $ (5,527) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income (loss) | (17,480) | (17,480) | |||
Foreign currency translation adjustments | 1,806 | 1,806 | |||
Unrealized gain (loss) on cash flow hedge | (2,199) | (2,199) | |||
Employee stock awards and stock options (in shares) | 535 | ||||
Employee stock awards and stock options | 5 | $ 5 | |||
Taxes withheld on stock compensation awards | (12,806) | (12,806) | |||
Stock-based compensation | 12,066 | 12,066 | |||
Balance (in shares) at Mar. 31, 2023 | 31,005 | ||||
Balance at Mar. 31, 2023 | 978,471 | $ 310 | 748,137 | 235,944 | (5,920) |
Balance (in shares) at Dec. 31, 2023 | 31,192 | ||||
Balance at Dec. 31, 2023 | 990,800 | $ 312 | 762,324 | 230,851 | (2,687) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income (loss) | 1,144 | 1,144 | |||
Foreign currency translation adjustments | (2,843) | (2,843) | |||
Unrealized gain (loss) on cash flow hedge | 5,351 | 5,351 | |||
Employee stock awards and stock options (in shares) | 261 | ||||
Employee stock awards and stock options | 3 | $ 3 | |||
Taxes withheld on stock compensation awards | (5,702) | (5,702) | |||
Stock-based compensation | 4,983 | 4,983 | |||
Balance (in shares) at Mar. 29, 2024 | 31,453 | ||||
Balance at Mar. 29, 2024 | $ 993,736 | $ 315 | $ 761,605 | $ 231,995 | $ (179) |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 29, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business V2X, Inc., an Indiana Corporation, formerly known as Vectrus, Inc. (Vectrus), is a leading provider of critical mission solutions and support to defense clients globally. The Company operates as one segment and delivers a comprehensive suite of integrated solutions and critical service offerings across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. Unless the context otherwise requires or unless stated otherwise, references in these notes to "V2X", "we," "us," "our," “combined company”, "the Company" and "our Company" refer to V2X, Inc. and all of its consolidated subsidiaries, taken together as a whole. Equity Investments In 2011, the Company entered into a joint venture agreement with Shaw Environmental & Infrastructure, Inc., which is now APTIM Federal Services LLC. Pursuant to the joint venture agreement, High Desert Support Services, LLC (HDSS) was established to pursue and perform work on the Ft. Irwin Installation Support Services Contract, which was awarded to HDSS in October 2012. In 2018, the Company entered into a joint venture agreement with J&J Maintenance. Pursuant to the joint venture agreement, J&J Facilities Support, LLC (J&J) was established to pursue and perform work on various U.S. government contracts. In 2020, the Company entered into a joint venture agreement with Kuwait Resources House for Human Resources Management and Services Company . Pursuant to the joint venture agreement, ServCore Resources and Services Solutions, LLC (ServCore) was established to operate and manage labor and life support services outside of the continental United States at designated locations serviced by V2X and others around the world. The Company accounts for its investments in HDSS, J&J, and ServCore under the equity method and has the ability to exercise significant influence but does not hold a controlling interest. The Company's proportionate 25%, 50%, and 40% shares, respectively, of income or losses from HDSS, J&J, and ServCore are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Income (Loss). The Company's investment in these joint ventures is recorded in other non-current assets in the Condensed Consolidated Balance Sheets. When cash distributions are received by the Company from its equity method investments, the cash distribution is compared to cumulative earnings and cumulative cash distributions. Cash distributions received are recorded as a return on investment in operating cash flows within the Condensed Consolidated Statements of Cash Flows to the extent cumulative cash distributions are less than cumulative earnings. Any cash distributions in excess of cumulative earnings are recorded as a return of investment in investing cash flows within the Condensed Consolidated Statements of Cash Flows. As of March 29, 2024 and December 31, 2023, the Company's combined investment balance was $4.8 million and $5.4 million, respectively. The Company's proportionate share of income from equity method investments was $2.6 million and $1.8 million for the three months ended March 29, 2024 and March 31, 2023 , respectively. Basis of Presentation The Company's quarterly financial periods end on the Friday closest to the last day of the calendar quarter (March 29, 2024 for the first quarter of 2024 and March 31, 2023 for the first quarter of 2023), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended. The unaudited interim Condensed Consolidated Financial Statements of V2X have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results. Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no material impact on the results of operations, financial position, or changes in shareholders’ equity. Restricted Cash As of March 29, 2024, the Company had total cash, cash equivalents, and restricted cash of $35.7 million which included $2.1 million of restricted cash. The Company's restricted cash was $2.0 million as of December 31, 2023. Related Party Transactions During the three months ended March 29, 2024 and March 31, 2023, the Company recorded income of $0.5 million and $0.7 million, respectively, related to a Transition Services Agreement with Crestview Aerospace LLC (Crestview). The income was recorded as a reduction in cost of sales. Crestview is a subsidiary of American Industrial Partners Capital Fund VI, L.P. (AIP), an affiliate of the majority shareholder of the Company. |
Recent Accounting Standards Upd
Recent Accounting Standards Update | 3 Months Ended |
Mar. 29, 2024 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
Recent Accounting Standards Update | RECENT AC COUNTING STANDARDS UPDATE In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280), to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. Amongst other amendments, the standard requires annual and interim disclosures of significant segment expenses that are regularly provided to the chief operating decision maker (CODM), and interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually. This standard does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740) to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this ASU are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements. |
Revenue
Revenue | 3 Months Ended |
Mar. 29, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | REVENUE Remaining Performance Obligations Remaining performance obligations represent firm orders by the customer and excludes potential orders under indefinite delivery and indefinite quantity (IDIQ) contracts, unexercised contract options and contracts awarded to us that are being protested by competitors with the U.S. Government Accountability Office (GAO) or in the U.S. Court of Federal Claims (COFC). The level of order activity related to programs can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others. The Company's contracts are multi-year contracts and typically include an initial period of one year or less with annual one year (or less) option periods. The number of option periods varies by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. government when the Company is the prime contractor or of the prime contractor when the Company is a subcontractor. The Company expects to recognize a substantial portion of its performance obligations as revenue within the next 12 months. However, the U.S. government or the prime contractor may cancel any contract at any time through a termination for convenience or for cause. Substantially all the Company's contracts have terms that would permit recovery of all or a portion of the Company's incurred costs and fees for work performed in the event of a termination for convenience. Remaining performance obligations are presented in the following table: March 29, December 31, (In millions) 2024 2023 Performance Obligations $ 3,268 $ 3,629 As of March 29, 2024, the Company expects to recognize approximately 63% and 37% of these remaining performance obligations as revenue in 2024 and 2025, respectively. Contract Estimates The impact of adjustments in contract estimates on the Company's operating income can be reflected in either revenue or cost of revenue. Cumulative adjustments for the three months ended March 29, 2024 and March 31, 2023 were favorable by $0.5 million and $13.1 million, respectively. For the three months ended March 29, 2024 and March 31, 2023, the net adjustments to operating income increased revenue by $3.4 million and $13.9 million, respectively. Revenue by Category Generally, the sales price elements for the Company's contracts are cost-plus, cost-reimbursable, firm-fixed-price and time-and-materials, all of which are commonly identified with a single contract. On a cost-plus contract, the Company is paid allowable incurred costs plus a profit, which can be fixed or variable depending on the contract’s fee arrangement, up to funding levels predetermined by the Company's customers. On cost-plus contracts, the Company does not bear the risks of unexpected cost overruns, provided that incurred costs do not exceed the predetermined funded amounts. Most of the Company's cost-plus contracts also contain a firm-fixed-price element. Cost-plus contracts with award and incentive fee provisions are primarily variable contract fee arrangements. Award fees provide for a fee based on actual performance relative to contractually specified performance criteria. Incentive fees are based on the relationship between total allowable and target cost. Most of the Company's contracts include a cost-reimbursable element to capture costs of consumable materials required for the program. Typically, these costs do not bear fees. On a firm-fixed-price contract, the Company agrees to perform the contractual statement of work for a predetermined contract price. A firm-fixed-price contract typically offers higher profit margin potential than a cost-plus contract, which is commensurate with the greater levels of risk assumed on a firm-fixed-price contract. Although a firm-fixed-price contract generally permits retention of profits if the total actual contract costs are less than the estimated contract costs, the Company bears the risk that increased or unexpected costs may reduce profit or cause the Company to sustain losses on the contract. Although the overall scope of work required under the contract may not change, profit may be adjusted as experience is gained and as efficiencies are realized or costs are incurred. On a time-and-materials contract, the Company is reimbursed for labor at fixed hourly rates and generally reimbursed separately for allowable materials, costs and expenses at cost. For this contract type, the Company bears the risk that labor costs and allocable indirect expenses are greater than the fixed hourly rate defined within the contract. The following tables present various revenue disaggregations. Revenue by contract type is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Cost-plus and cost-reimbursable $ 604,167 $ 523,030 15.5 % Firm-fixed-price 379,272 385,112 (1.5) % Time-and-materials 27,125 35,318 (23.2) % Total revenue $ 1,010,564 $ 943,460 Revenue by geographic region in which the contract is performed is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change United States $ 544,726 $ 548,770 (0.7) % Middle East 343,216 281,121 22.1 % Asia 68,802 64,317 7.0 % Europe 53,820 49,252 9.3 % Total revenue $ 1,010,564 $ 943,460 Revenue by contract relationship is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Prime contractor $ 945,155 $ 879,179 7.5 % Subcontractor 65,409 64,281 1.8 % Total revenue $ 1,010,564 $ 943,460 Revenue by customer is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Army $ 433,430 $ 390,503 11.0 % Navy 321,384 292,690 9.8 % Air Force 118,569 129,981 (8.8) % Other 137,181 130,286 5.3 % Total revenue $ 1,010,564 $ 943,460 Contract Balances The timing of revenue recognition, billings, and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, the Company may receive advances or deposits from its customers before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to ensure that both parties are in conformance with the primary contract terms. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. As of January 1, 2023, the Company had contract assets of $487.8 million. As of March 29, 2024 and December 31, 2023, the Company had contract assets of $658.9 million and $561.9 million, respectively. Contract assets primarily consist of unbilled receivables which represent rights to consideration for work completed but not billed as of the reporting date. The balance of unbilled receivables consists of costs and fees that are: (i) billable immediately; (ii) billable on contract completion; or (iii) billable upon other specified events, such as the resolution of a request for equitable adjustment. Refer to Note Receivables for additional information regarding the composition of the Company's receivable balances. As of January 1, 2023, the Company had contract liabilities of $76.4 million. As of March 29, 2024 and December 31, 2023, contract liabilities, included in other accrued liabilities in the Condensed Consolidated Balance Sheets, were $142.0 million and $109.6 million, respectively. |
Receivables
Receivables | 3 Months Ended |
Mar. 29, 2024 | |
Receivables [Abstract] | |
Receivables | RECEIVABLES Receivables were comprised of the following: March 29, December 31, (In thousands) 2024 2023 Billed receivables $ 117,203 $ 109,318 Unbilled receivables (contract assets) 658,893 561,862 Other 12,394 34,815 Total receivables $ 788,490 $ 705,995 As of March 29, 2024 and December 31, 2023, substantially all billed receivables are due from the U.S. government, either directly as prime contractor to the U.S. government or as subcontractor to another prime contractor to the U.S. government. Because the Company's billed receivables are with the U.S. government, the Company does not believe it has a material credit risk exposure. Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. The Company expects to bill customers for most of the March 29, 2024 contract assets during 2024. Changes in the balance of receivables are primarily due to the timing differences between performance and customers' payments. SALE OF RECEIVABLES The Company has a Master Accounts Receivable Purchase Agreement (MARPA Facility) with MUFG Bank, Ltd. (MUFG) for the sale of certain designated eligible receivables up to a maximum amount of $200.0 million with the U.S. government. Receivables sold under the MARPA Facility are without recourse for any U.S. government credit risk. The Company accounts for these receivable transfers under the MARPA Facility as sales under ASC Topic 860, Transfers and Servicing , and removes the sold receivables from its balance sheet. The fair value of the sold receivables approximated their book value due to their short-term nature. As of and for the Three Months Ended March 29, (In thousands) 2024 Beginning balance: $ 72,715 Sale of receivables 621,920 Cash collections (588,266) Outstanding balance sold to MUFG 1 106,369 Cash collected, not remitted to MUFG 2 (24,167) Remaining sold receivables $ 82,202 1 For the three months ended March 29, 2024, the Company recorded a net cash inflow from sale of receivables of $33.7 million from operating activities. 2 Includes the cash collected on behalf of, but not yet remitted to, MUFG as of March 29, 2024. This balance is included in other accrued liabilities as of the balance sheet date. During the three months ended March 29, 2024, the Company incurred purchase discount fees, net of servicing fees, of $1.6 million, which are presented in other expense, net on the Condensed Consolidated Statements of Income (Loss) and are reflected as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows. The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services. The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of March 29, 2024. Proceeds from the sale of receivables are reflected as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows. |
Debt
Debt | 3 Months Ended |
Mar. 29, 2024 | |
Debt Disclosure [Abstract] | |
Debt | DEBT Senior Secured Credit Facilities First Lien Credit Agreement The First Lien Credit Agreement provides for a tranche of term loans in an aggregate original principal amount of $911.1 million. The loans under the First Lien Credit Agreement amortize in an amount equal to approximately $2.3 million per quarter through September 30, 2028, with the balance of $865.6 million due on December 6, 2028. Vertex Aerospace Services LLC (Vertex Borrower) obligations under the First Lien Credit Agreement are guaranteed by Vertex Intermediate LLC and Vertex Borrower’s wholly-owned domestic subsidiaries (collectively, the Guarantors), subject to customary exceptions and limitations. The Vertex Borrower’s obligations under the First Lien Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority-lien on substantially all the Vertex Borrower’s and the Guarantors’ assets which exists on a pari passu basis with the lien held by the 2023 Credit Agreement lenders. The borrowings under the First Lien Credit Agreement bear interest at rates that, at the Vertex Borrower’s option, can be either a base rate, determined by reference to the greater of (a) the federal funds rate plus 0.50%, (b) the prime lending rate, or (c) an adjusted Secured Overnight Financing Rate (SOFR) rate plus 1.00%, plus a margin of 2.25% per annum, or SOFR, plus a margin of 3.25% per annum. As of March 29, 2024, the effective interest rate for the First Lien Credit Agreement was 9.48%. The First Lien Credit Agreement contains customary representations and warranties and affirmative covenants. The First Lien Credit Agreement also includes negative covenants that limit, among other things, additional indebtedness, additional liens, sales of assets, dividends, investments and advances, prepayments of debt and mergers and acquisitions. The First Lien Credit Agreement contains customary events of default, including, but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the First Lien Credit Agreement to be in full force and effect, and a change of control. If an event of default occurs and is continuing, the Vertex Borrower may be required immediately to repay all amounts outstanding under the First Lien Credit Agreement. As of March 29, 2024, the carrying value of the First Lien Credit Agreement was $906.6 million, excluding deferred discount and unamortized deferred financing costs of $34.7 million. The estimated fair value of the First Lien Credit Agreement as of March 29, 2024 was $908.8 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2). 2023 Credit Agreement The 2023 Credit Agreement provides for $750.0 million in senior secured financing, with a first lien on substantially all the Vertex Borrower’s assets and consists of (a) a $500.0 million five-year revolving credit facility (2023 Revolver) (which includes (i) a $50.0 million sublimit of availability for letters of credit, and (ii) a $50.0 million sublimit for short-term borrowings on a swingline basis) and (b) a five-year $250.0 million term loan (2023 Term Loan). The 2023 Term Loan amortizes at approximately $1.6 million per quarter for the fiscal quarters ending June 30, 2023 through March 31, 2025, increasing to $3.1 million per quarter for the fiscal quarters ending June 30, 2025 through December 31, 2027, with the balance of $203.1 million due on February 28, 2028. The Vertex Borrower’s obligations under the 2023 Credit Agreement are guaranteed by the Guarantors, subject to customary exceptions and limitations. The Vertex Borrower’s obligations under the 2023 Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority-lien on substantially all of the Vertex Borrower’s and the Guarantors’ assets (subject to customary exceptions and limitations) which exists on a pari passu basis with the lien held by the First Lien Credit Agreement lenders. The borrowings under the 2023 Credit Agreement bear interest at rates that, at the Vertex Borrower’s option, can be either a base rate, determined by reference to the greater of (a) the federal funds rate plus 0.50%, (b) the prime lending rate, or (c) an adjusted SOFR rate plus 1.00%, plus a margin of 1.00% to 2.25% per annum, or SOFR, plus a margin of 2.00% to 3.25% per annum, in each case, depending on the consolidated total net leverage ratio of the Vertex Borrower and its subsidiaries. As of March 29, 2024, the effective interest rates for the 2023 Revolver and Term Loan were 9.14% and 8.38%, respectively. Unutilized commitments under the 2023 Revolver are subject to a per annum fee ranging from 0.25% to 0.50% depending on the consolidated total net leverage ratio of the Vertex Borrower and its subsidiaries. The Vertex Borrower is also required to pay a letter of credit fronting fee to each letter of credit issuer equal to 0.125% per annum of the amount available to be drawn under each such letter of credit (or such other amount as may be mutually agreed by the Vertex Borrowers and the applicable letter of credit issuer), as well as a fee to all lenders equal to the applicable margin to SOFR of revolving credit loans times the average daily amount available to be drawn under all outstanding letters of credit. The 2023 Credit Agreement contains customary representations and warranties, which must be accurate for the Vertex Borrower to borrow under the 2023 Credit Agreement, and affirmative covenants. The 2023 Credit Agreement also includes negative covenants that limit, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions. The 2023 Credit Agreement contains financial covenants requiring (a) the consolidated total net leverage ratio not to exceed 5.00 to 1.00 for the reporting periods ending on or after June 30, 2023, and on or prior to June 30, 2024, with further step downs thereafter, and (b) the consolidated interest coverage ratio be at least 2.00 to 1.00 commencing with the reporting period ending on June 30, 2023. The 2023 Credit Agreement contains customary events of default, including, but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the 2023 Credit Agreement to be in full force and effect, and a change of control. If an event of default occurs and is continuing, the Borrowers may be required immediately to repay all amounts outstanding under the 2023 Credit Agreement. As of March 29, 2024, there were $56.0 million of outstanding borrowings and $17.2 million of outstanding letters of credit under the 2023 Revolver. Availability under the 2023 Revolver was $426.8 million as of March 29, 2024. Unamortized deferred financing costs related to the 2023 Revolver of $3.9 million are included in other non-current assets in the Condensed Consolidated Balance Sheets. As of March 29, 2024, the fair value of the 2023 Revolver approximated the carrying value because the debt bears a floating interest rate. As of March 29, 2024, the carrying value of the 2023 Term Loan was $243.8 million, excluding unamortized deferred financing costs of $2.0 million. The estimated fair value of the 2023 Term Loan as of March 29, 2024 was $244.1 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2). The aggregate scheduled maturities of the First Lien Credit Agreement and 2023 Credit Agreement as of March 29, 2024 are as follows: (In thousands) Payments due 2024 (remainder of the year) $ 11,521 2025 20,049 2026 21,611 2027 21,611 2028 1,131,527 Total $ 1,206,319 |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Mar. 29, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | DERIVATIVE INSTRUMENTS During the periods covered by this report, the Company has made no changes to its policies or strategies for the use of derivative instruments and there has been no change in related accounting methods. For the Company's derivative instruments, which are designated as cash flow hedges, gains and losses are initially reported as a component of accumulated other comprehensive income (loss) and subsequently recognized in earnings with the corresponding hedged item. Interest Rate Derivative Instruments The Company is exposed to the risk that the earnings and cash flows could be adversely impacted due to fluctuations in interest rates. To mitigate this risk, the Company entered into $350.0 million of interest rate swap contracts during the first six months of 2023. As of March 29, 2024 and December 31, 2023, these contracts had notional values of $343.8 million and $345.3 million, respectively. These contracts are designated and qualify as effective cash flow hedges. The following table summarizes the amount at fair value and location of the derivative instruments for interest rate hedges in the Condensed Consolidated Balance Sheets as of March 29, 2024: (In thousands) Fair Value (level 2) Balance sheet caption Amount Interest rate swap designated as cash flow hedge Prepaid expenses and other current assets $ 4,095 Interest rate swap designated as cash flow hedge Other non-current assets $ 1,201 Interest rate swap designated as cash flow hedge Accumulated other comprehensive income $ 5,296 The Company regularly assesses the creditworthiness of the counterparty. As of March 29, 2024, the counterparty to the interest rate swaps had performed in accordance with its contractual obligations. Both the counterparty credit risk and the Company's credit risk were considered in the fair value determination. Net interest rate derivative gains of $1.5 million and a nominal amount were recognized in interest expense, net, in the Condensed Consolidated Statements of Income (Loss) during the three months ended March 29, 2024 and March 31, 2023, respectively. The Company expects $4.3 million of existing interest rate swap gains reported in accumulated other comprehensive income as of March 29, 2024 to be recognized in earnings within the next 12 months. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 29, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES General From time to time, the Company is involved in various investigations, lawsuits, arbitrations, claims, enforcement actions and other legal proceedings, including government investigations and claims, which are incidental to the operation of its business. Some of these proceedings seek remedies relating to employment matters, matters relating to injuries to people or property damage, matters in connection with the Company's contracts and matters arising under laws relating to the protection of the environment. Additionally, U.S. government customers periodically advise the Company of claims and penalties concerning certain potential disallowed costs. When such findings are presented, V2X and the U.S. government representatives engage in discussions to enable V2X to evaluate the merits of these claims as well as to assess the amounts being claimed. Where appropriate, provisions are made to reflect probable losses related to the matters raised by U.S. government representatives. Such assessments, along with any assessments regarding provisions for other legal proceedings, are reviewed on a quarterly basis for sufficiency based on the latest information available to us. The Company estimated and accrued $12.4 million and $12.1 million as of March 29, 2024 and December 31, 2023, respectively, in other accrued liabilities in the Condensed Consolidated Balance Sheets for legal proceedings and for claims with respect to its U.S. government contracts as discussed below, including years where the U.S. government has not completed its incurred cost audits. Although the ultimate outcome of any legal matter or claim cannot be predicted with certainty, based on present information, including the assessment of the merits of a particular claim, the Company does not expect that any asserted or unasserted legal or contractual claims or proceedings, individually or in the aggregate, will have a material adverse effect on its cash flows, results of operations or financial condition. U.S. Government Contracts, Investigations and Claims The Company has U.S. government contracts that are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could have a material adverse effect on the Company's financial condition or results of operations. Furthermore, the Company's contracts with the U.S. government may be terminated or suspended by the U.S. government at any time, with or without cause. Such contract suspensions or terminations could result in non-reimbursable expenses or charges or otherwise adversely affecting the Company's financial condition and results of operations. Departments and agencies of the U.S. government have the authority to investigate various transactions and operations of the Company, and the results of such investigations may lead to administrative, civil or criminal proceedings, the ultimate outcome of which could be fines, penalties, repayments or compensatory or treble damages. U.S. government regulations provide that certain findings against a contractor may lead to suspension or debarment from future U.S. government contracts or the loss of export privileges for a company or an operating division or subdivision. Suspension or debarment could have a material adverse effect on the Company because of its reliance on U.S. government contracts. U.S. government agencies, including the Defense Contract Audit Agency, the Defense Contract Management Agency and others, routinely audit and review the Company's performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. Accordingly, costs billed or billable to U.S. government customers are subject to potential adjustment upon audit by such agencies. The U.S. government agencies also review the adequacy of compliance with government standards for business systems, including accounting, earned value management, estimating, materials management and accounting, purchasing, and property management systems. A finding by a U.S. government agency that the Company’s business systems are not adequate could adversely affect the Company’s financial condition and results of operations. In the performance of its contracts, the Company routinely requests contract modifications that require additional funding from U.S. government customers. Most often, these requests are due to customer-directed changes in the scope of work. While the Company is entitled to recovery of these costs under its contracts, the administrative process with the U.S. government customer may be protracted. Based on the circumstances, the Company periodically files requests for equitable adjustments (REAs) that are sometimes converted into claims. In some cases, these requests are disputed by the U.S. government customer. The Company believes its outstanding modifications, REAs and other claims will be resolved without material adverse impact to its results of operations, financial condition or cash flows. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 29, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | STOCK-BASED COMPENSATION The Company maintains an equity incentive plan, the 2014 Omnibus Incentive Plan, as amended and restated effective as of October 27, 2022 (the 2014 Omnibus Plan), to govern awards granted to V2X employees and directors, including nonqualified stock options (NQOs), restricted stock units (RSUs), total shareholder return (TSR) awards, performance share units (PSUs) and other awards. The Company accounts for NQOs, stock-settled RSUs and PSUs as equity-based compensation awards. TSR awards, described below, are accounted for as liability-based compensation awards. Liability-based awards are revalued at the end of each reporting period to reflect changes in fair value. Stock-based compensation expense and the associated tax benefits impacting the Company's Condensed Consolidated Statements of Income (Loss) were as follows: Three Months Ended March 29, March 31, (In thousands) 2024 2023 Compensation costs for equity-based awards $ 4,983 $ 12,066 Compensation costs for liability-based awards 166 806 Total compensation costs, pre-tax $ 5,149 $ 12,872 Future tax benefit $ 1,065 $ 2,971 As of March 29, 2024, total unrecognized compensation costs related to equity-based awards and liability-based awards were $26.6 million and $0.5 million, respectively, which are expected to be recognized ratably over a weighted average period of 1.85 years and 0.76 years, respectively. The following table provides a summary of the activities for NQOs, RSUs and PSUs for the three months ended March 29, 2024: NQOs RSUs PSUs (In thousands, except per share data) Shares Weighted Average Exercise Price Per Share Shares Weighted Average Grant Date Fair Value Per Share Shares Weighted Average Grant Date Fair Value Per Share Outstanding at January 1, 2024 40 $ 22.93 800 $ 37.29 267 $ 43.45 Granted — $ — 251 $ 44.92 96 $ 44.92 Exercised — $ — (397) $ 42.15 — $ — Vested — $ — — $ — — $ — Forfeited or expired — $ — (29) $ 39.83 (34) $ 39.45 Outstanding at March 29, 2024 40 $ 22.93 625 $ 40.86 329 $ 41.88 Restricted Stock Units RSUs awarded to employees vest in one-third increments on each of the three anniversary dates following the grant date subject to continued employment as described in the RSU award agreement. RSUs issued to directors are typically granted annually and vest approximately one year after the grant date. The fair value of each RSU grant was determined based on the closing price of V2X common stock on the date of grant. Stock compensation expense will be recognized ratably over the requisite service period of the RSU awards. As of March 29, 2024, there was $18.5 million of unrecognized RSU related compensation expense. Total Shareholder Return Awards TSR awards are performance-based cash awards that are subject to a three-year performance period. Any payments earned are made in cash following completion of the performance period according to the achievement of specified performance goals. There were no cash-based TSR awards granted in the first quarter of 2024. As of March 29, 2024, there was $0.5 million of unrecognized TSR related compensation expense. Performance Share Units During the first quarter of 2024, the Company granted performance-based awards with market conditions. The awards will vest and the stock will be issued at the end of a three-year period based on the attainment of certain total shareholder return performance measures as compared to peer group companies, and the employee's continued service through the vesting date. The number of shares ultimately awarded, if any, can range up to 200% of the specified target awards. If performance is below the threshold level of performance, no shares will be issued. As of March 29, 2024, there was $8.1 million of unrecognized PSU related compensation expense. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 29, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | INCOME TAXES Effective Tax Rate Income tax expense during interim periods is based on an estimated annual effective income tax rate, plus discrete items that may occur in any given interim periods. The computation of the estimated effective income tax rate at each interim period requires certain estimates and judgment including, but not limited to, forecasted operating income for the year, projections of the income earned and taxed in various jurisdictions, newly enacted tax rate and legislative changes, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. For the three months ended March 29, 2024 and March 31, 2023, the Company recorded income tax benefits which were not material and $5.7 million, respectively. The Company's effective income tax rates for the three months ended March 29, 2024 and March 31, 2023 were (1.8)% and 24.7%, respectively. The effective income tax rates vary from the federal statutory rate of 21.0% mainly due to state and foreign taxes, disallowed compensation deduction under Internal Revenue Code Section 162(m), offset by available deductions not reflected in book income and income tax credits. Uncertain Tax Positions As of March 29, 2024 and December 31, 2023, unrecognized tax benefits from uncertain tax positions were $6.6 million and $6.6 million, respectively. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 29, 2024 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | EARNINGS PER SHARE Basic earnings per share (EPS) is computed by dividing net income, or loss, by the weighted average number of common shares outstanding for the period. Diluted EPS reflects potential dilution that could occur if securities to issue common stock were exercised or converted into common stock. Diluted EPS includes the dilutive effect of stock-based compensation outstanding after application of the treasury stock method. Three Months Ended March 29, March 31, (In thousands, except per share data) 2024 2023 Net income (loss) $ 1,144 $ (17,480) Weighted average common shares outstanding 31,351 30,927 Add: Dilutive impact of stock options 18 — Add: Dilutive impact of restricted stock units 425 — Diluted weighted average common shares outstanding 31,794 30,927 Earnings (loss) per share Basic $ 0.04 $ (0.57) Diluted $ 0.04 $ (0.57) The following table summarizes the weighted average of anti-dilutive securities excluded from the diluted EPS calculation. Three Months Ended March 29, March 31, (In thousands) 2024 2023 Anti-dilutive stock options — — Anti-dilutive restricted stock units 25 — Total 25 — |
Post-Employment Benefit Plans
Post-Employment Benefit Plans | 3 Months Ended |
Mar. 29, 2024 | |
Retirement Benefits [Abstract] | |
Post-Employment Benefit Plans | POST-EMPLOYMENT BENEFIT PLANS Deferred Employee Compensation The Company sponsors two non-qualified deferred compensation plans. Under these plans, participants are eligible to defer a portion of their compensation on a tax deferred basis. Plan investments and obligations were recorded in other non-current assets and other non-current liabilities, respectively, in the Condensed Consolidated Balance Sheets, representing the fair value related to the deferred compensation plans. Adjustments to the fair value of the plan investments and obligations are recorded in selling, general, and administrative expenses. The plans assets and liabilities were $4.2 million and $3.2 million as of March 29, 2024 and December 31, 2023, respectively. Multi-Employer Pension Plans C ertain Company employees who perform work on contracts within the continental United States participate in multi-employer pension plans of which the Company is not the sponsor. Company expenses related to these plans were $5.0 million and $3.3 million for the three months ended March 29, 2024 and March 31, 2023, respectively. |
Sale of Receivables
Sale of Receivables | 3 Months Ended |
Mar. 29, 2024 | |
Receivables [Abstract] | |
Sale of Receivables | RECEIVABLES Receivables were comprised of the following: March 29, December 31, (In thousands) 2024 2023 Billed receivables $ 117,203 $ 109,318 Unbilled receivables (contract assets) 658,893 561,862 Other 12,394 34,815 Total receivables $ 788,490 $ 705,995 As of March 29, 2024 and December 31, 2023, substantially all billed receivables are due from the U.S. government, either directly as prime contractor to the U.S. government or as subcontractor to another prime contractor to the U.S. government. Because the Company's billed receivables are with the U.S. government, the Company does not believe it has a material credit risk exposure. Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. The Company expects to bill customers for most of the March 29, 2024 contract assets during 2024. Changes in the balance of receivables are primarily due to the timing differences between performance and customers' payments. SALE OF RECEIVABLES The Company has a Master Accounts Receivable Purchase Agreement (MARPA Facility) with MUFG Bank, Ltd. (MUFG) for the sale of certain designated eligible receivables up to a maximum amount of $200.0 million with the U.S. government. Receivables sold under the MARPA Facility are without recourse for any U.S. government credit risk. The Company accounts for these receivable transfers under the MARPA Facility as sales under ASC Topic 860, Transfers and Servicing , and removes the sold receivables from its balance sheet. The fair value of the sold receivables approximated their book value due to their short-term nature. As of and for the Three Months Ended March 29, (In thousands) 2024 Beginning balance: $ 72,715 Sale of receivables 621,920 Cash collections (588,266) Outstanding balance sold to MUFG 1 106,369 Cash collected, not remitted to MUFG 2 (24,167) Remaining sold receivables $ 82,202 1 For the three months ended March 29, 2024, the Company recorded a net cash inflow from sale of receivables of $33.7 million from operating activities. 2 Includes the cash collected on behalf of, but not yet remitted to, MUFG as of March 29, 2024. This balance is included in other accrued liabilities as of the balance sheet date. During the three months ended March 29, 2024, the Company incurred purchase discount fees, net of servicing fees, of $1.6 million, which are presented in other expense, net on the Condensed Consolidated Statements of Income (Loss) and are reflected as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows. The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services. The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of March 29, 2024. Proceeds from the sale of receivables are reflected as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows. |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 29, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Our Business and Basis of Presentation | Business V2X, Inc., an Indiana Corporation, formerly known as Vectrus, Inc. (Vectrus), is a leading provider of critical mission solutions and support to defense clients globally. The Company operates as one segment and delivers a comprehensive suite of integrated solutions and critical service offerings across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. Unless the context otherwise requires or unless stated otherwise, references in these notes to "V2X", "we," "us," "our," “combined company”, "the Company" and "our Company" refer to V2X, Inc. and all of its consolidated subsidiaries, taken together as a whole. Basis of Presentation The Company's quarterly financial periods end on the Friday closest to the last day of the calendar quarter (March 29, 2024 for the first quarter of 2024 and March 31, 2023 for the first quarter of 2023), except for the last quarter of the fiscal year, which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as three months ended. The unaudited interim Condensed Consolidated Financial Statements of V2X have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been omitted. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company’s financial position and operating results. Revenue and net income for any interim period are not necessarily indicative of future or annual results. Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no material impact on the results of operations, financial position, or changes in shareholders’ equity. |
Equity Investments | Equity Investments In 2011, the Company entered into a joint venture agreement with Shaw Environmental & Infrastructure, Inc., which is now APTIM Federal Services LLC. Pursuant to the joint venture agreement, High Desert Support Services, LLC (HDSS) was established to pursue and perform work on the Ft. Irwin Installation Support Services Contract, which was awarded to HDSS in October 2012. In 2018, the Company entered into a joint venture agreement with J&J Maintenance. Pursuant to the joint venture agreement, J&J Facilities Support, LLC (J&J) was established to pursue and perform work on various U.S. government contracts. In 2020, the Company entered into a joint venture agreement with Kuwait Resources House for Human Resources Management and Services Company . Pursuant to the joint venture agreement, ServCore Resources and Services Solutions, LLC (ServCore) was established to operate and manage labor and life support services outside of the continental United States at designated locations serviced by V2X and others around the world. The Company accounts for its investments in HDSS, J&J, and ServCore under the equity method and has the ability to exercise significant influence but does not hold a controlling interest. The Company's proportionate 25%, 50%, and 40% shares, respectively, of income or losses from HDSS, J&J, and ServCore are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Income (Loss). The Company's investment in these joint ventures is recorded in other non-current assets in the Condensed Consolidated Balance Sheets. When cash distributions are received by the Company from its equity method investments, the cash distribution is compared to cumulative earnings and cumulative cash distributions. Cash distributions received are recorded as a return on investment in operating cash flows within the Condensed Consolidated Statements of Cash Flows to the extent cumulative cash distributions are less than cumulative earnings. Any cash distributions in excess of cumulative earnings are recorded as a return of investment in investing cash flows within the Condensed Consolidated Statements of Cash Flows. As of March 29, 2024 and December 31, 2023, the Company's combined investment balance was $4.8 million and $5.4 million, respectively. The Company's proportionate share of income from equity method investments was $2.6 million and $1.8 million for the three months ended March 29, 2024 and March 31, 2023 , respectively. |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Remaining Performance Obligation | Remaining performance obligations are presented in the following table: March 29, December 31, (In millions) 2024 2023 Performance Obligations $ 3,268 $ 3,629 |
Disaggregation of Revenue | The following tables present various revenue disaggregations. Revenue by contract type is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Cost-plus and cost-reimbursable $ 604,167 $ 523,030 15.5 % Firm-fixed-price 379,272 385,112 (1.5) % Time-and-materials 27,125 35,318 (23.2) % Total revenue $ 1,010,564 $ 943,460 Revenue by geographic region in which the contract is performed is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change United States $ 544,726 $ 548,770 (0.7) % Middle East 343,216 281,121 22.1 % Asia 68,802 64,317 7.0 % Europe 53,820 49,252 9.3 % Total revenue $ 1,010,564 $ 943,460 Revenue by contract relationship is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Prime contractor $ 945,155 $ 879,179 7.5 % Subcontractor 65,409 64,281 1.8 % Total revenue $ 1,010,564 $ 943,460 Revenue by customer is as follows: Three Months Ended March 29, March 31, % (In thousands) 2024 2023 Change Army $ 433,430 $ 390,503 11.0 % Navy 321,384 292,690 9.8 % Air Force 118,569 129,981 (8.8) % Other 137,181 130,286 5.3 % Total revenue $ 1,010,564 $ 943,460 |
Receivables (Tables)
Receivables (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Receivables [Abstract] | |
Schedule of Receivables | Receivables were comprised of the following: March 29, December 31, (In thousands) 2024 2023 Billed receivables $ 117,203 $ 109,318 Unbilled receivables (contract assets) 658,893 561,862 Other 12,394 34,815 Total receivables $ 788,490 $ 705,995 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Maturities of Long-term Debt | The aggregate scheduled maturities of the First Lien Credit Agreement and 2023 Credit Agreement as of March 29, 2024 are as follows: (In thousands) Payments due 2024 (remainder of the year) $ 11,521 2025 20,049 2026 21,611 2027 21,611 2028 1,131,527 Total $ 1,206,319 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Liabilities at Fair Value | The following table summarizes the amount at fair value and location of the derivative instruments for interest rate hedges in the Condensed Consolidated Balance Sheets as of March 29, 2024: (In thousands) Fair Value (level 2) Balance sheet caption Amount Interest rate swap designated as cash flow hedge Prepaid expenses and other current assets $ 4,095 Interest rate swap designated as cash flow hedge Other non-current assets $ 1,201 Interest rate swap designated as cash flow hedge Accumulated other comprehensive income $ 5,296 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Impact of Stock-Based Compensation in Consolidation and Combined Statements of Income | Stock-based compensation expense and the associated tax benefits impacting the Company's Condensed Consolidated Statements of Income (Loss) were as follows: Three Months Ended March 29, March 31, (In thousands) 2024 2023 Compensation costs for equity-based awards $ 4,983 $ 12,066 Compensation costs for liability-based awards 166 806 Total compensation costs, pre-tax $ 5,149 $ 12,872 Future tax benefit $ 1,065 $ 2,971 |
Schedule of Non-Qualified Stock Options, Activity | The following table provides a summary of the activities for NQOs, RSUs and PSUs for the three months ended March 29, 2024: NQOs RSUs PSUs (In thousands, except per share data) Shares Weighted Average Exercise Price Per Share Shares Weighted Average Grant Date Fair Value Per Share Shares Weighted Average Grant Date Fair Value Per Share Outstanding at January 1, 2024 40 $ 22.93 800 $ 37.29 267 $ 43.45 Granted — $ — 251 $ 44.92 96 $ 44.92 Exercised — $ — (397) $ 42.15 — $ — Vested — $ — — $ — — $ — Forfeited or expired — $ — (29) $ 39.83 (34) $ 39.45 Outstanding at March 29, 2024 40 $ 22.93 625 $ 40.86 329 $ 41.88 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Earnings Per Share [Abstract] | |
Reconciliation of Basic and Diluted Weighted Average Shares Outstanding | Three Months Ended March 29, March 31, (In thousands, except per share data) 2024 2023 Net income (loss) $ 1,144 $ (17,480) Weighted average common shares outstanding 31,351 30,927 Add: Dilutive impact of stock options 18 — Add: Dilutive impact of restricted stock units 425 — Diluted weighted average common shares outstanding 31,794 30,927 Earnings (loss) per share Basic $ 0.04 $ (0.57) Diluted $ 0.04 $ (0.57) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table summarizes the weighted average of anti-dilutive securities excluded from the diluted EPS calculation. Three Months Ended March 29, March 31, (In thousands) 2024 2023 Anti-dilutive stock options — — Anti-dilutive restricted stock units 25 — Total 25 — |
Sale of Receivables (Tables)
Sale of Receivables (Tables) | 3 Months Ended |
Mar. 29, 2024 | |
Receivables [Abstract] | |
Schedule of Receivables Sold | The fair value of the sold receivables approximated their book value due to their short-term nature. As of and for the Three Months Ended March 29, (In thousands) 2024 Beginning balance: $ 72,715 Sale of receivables 621,920 Cash collections (588,266) Outstanding balance sold to MUFG 1 106,369 Cash collected, not remitted to MUFG 2 (24,167) Remaining sold receivables $ 82,202 1 For the three months ended March 29, 2024, the Company recorded a net cash inflow from sale of receivables of $33.7 million from operating activities. 2 Includes the cash collected on behalf of, but not yet remitted to, MUFG as of March 29, 2024. This balance is included in other accrued liabilities as of the balance sheet date. |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Details) $ in Thousands | 3 Months Ended | |||
Mar. 29, 2024 USD ($) operatingSegment | Mar. 31, 2023 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Schedule of Equity Method Investments [Line Items] | ||||
Number of operating segments | operatingSegment | 1 | |||
Joint venture investment balance | $ 4,800 | $ 5,400 | ||
Proportionate share of income (loss) | 2,600 | $ 1,800 | ||
Cash, cash equivalents and restricted cash | 35,658 | 62,145 | 72,651 | $ 116,067 |
Restricted cash | 2,100 | $ 2,000 | ||
Net income (loss) | 1,144 | (17,480) | ||
Related Party | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Net income (loss) | $ 500 | $ 700 | ||
High Desert Support Services, LLC | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Ownership percentage | 25% | |||
J&J Maintenance | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Ownership percentage | 50% | |||
Servcore Resources and Services Solutions, LLC | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Ownership percentage | 40% |
Revenue - Revenue Performance O
Revenue - Revenue Performance Obligations (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | ||
Contract term | 1 year | |
Renewal option, term | 1 year | |
Performance Obligations | $ 3,268,000 | $ 3,629,000 |
Revenue - Revenue Performance_2
Revenue - Revenue Performance Obligations (Percentage and Remaining Period of Time) (Details) | Mar. 29, 2024 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-30 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, percentage | 63% |
Revenue, expected performance obligation, period | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, percentage | 37% |
Revenue, expected performance obligation, period | 1 year |
Revenue - Revenue Contract Esti
Revenue - Revenue Contract Estimates (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | ||
Favorable adjustments to operating income | $ 0.5 | $ 13.1 |
Favorable adjustments to revenue | $ 3.4 | $ 13.9 |
Revenue - Revenue by Contract T
Revenue - Revenue by Contract Type (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 1,010,564 | $ 943,460 |
Cost-plus and cost-reimbursable | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 604,167 | 523,030 |
Revenue, percent change | 15.50% | |
Firm-fixed-price | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 379,272 | 385,112 |
Revenue, percent change | (1.50%) | |
Time-and-materials | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 27,125 | $ 35,318 |
Revenue, percent change | (23.20%) |
Revenue - Revenue by Geographic
Revenue - Revenue by Geographic Region (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 1,010,564 | $ 943,460 |
United States | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 544,726 | 548,770 |
Revenue, percent change | (0.70%) | |
Middle East | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 343,216 | 281,121 |
Revenue, percent change | 22.10% | |
Asia | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 68,802 | 64,317 |
Revenue, percent change | 7% | |
Europe | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 53,820 | $ 49,252 |
Revenue, percent change | 9.30% |
Revenue - Revenue by Contract R
Revenue - Revenue by Contract Relationship (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 1,010,564 | $ 943,460 |
Prime contractor | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 945,155 | 879,179 |
Revenue, percent change | 7.50% | |
Subcontractor | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 65,409 | $ 64,281 |
Revenue, percent change | 1.80% |
Revenue - Revenue by Customer (
Revenue - Revenue by Customer (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 1,010,564 | $ 943,460 |
Army | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 433,430 | 390,503 |
Revenue, percent change | 11% | |
Navy | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 118,569 | 129,981 |
Revenue, percent change | (8.80%) | |
Air Force | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 321,384 | 292,690 |
Revenue, percent change | 9.80% | |
Other | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 137,181 | $ 130,286 |
Revenue, percent change | 5.30% |
Revenue - Revenue Contract Bala
Revenue - Revenue Contract Balances (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Dec. 31, 2023 | Dec. 31, 2022 |
Revenue from Contract with Customer [Abstract] | |||
Contract assets | $ 658.9 | $ 561.9 | $ 487.8 |
Contract liabilities | $ 142 | $ 109.6 | $ 76.4 |
Receivables - Schedule of Recei
Receivables - Schedule of Receivables (Details) - USD ($) $ in Thousands | Mar. 29, 2024 | Dec. 31, 2023 |
Receivables [Abstract] | ||
Billed receivables | $ 117,203 | $ 109,318 |
Unbilled receivables (contract assets) | 658,893 | 561,862 |
Other | 12,394 | 34,815 |
Total receivables | $ 788,490 | $ 705,995 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Feb. 28, 2023 | Jul. 05, 2022 | Mar. 29, 2024 | Mar. 31, 2023 | |
Debt Instrument [Line Items] | ||||
Prepayment premium on early redemption of debt | $ 0 | $ 1,600 | ||
Letters of credit | 2023 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Outstanding borrowings | $ 17,200 | |||
Secured Debt | First Lien Initial Term Tranche | ||||
Debt Instrument [Line Items] | ||||
Interest rate | 9.48% | |||
Secured Debt | Vertex First Lien Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Total | $ 906,600 | |||
Deferred debt issuance costs | (34,700) | |||
Fair value | 908,800 | |||
Quarterly amortization | $ 2,300 | |||
Secured Debt | Vertex First Lien Term Facility | ||||
Debt Instrument [Line Items] | ||||
Face amount | 865,600 | |||
Secured Debt | New Term Loans | ||||
Debt Instrument [Line Items] | ||||
Face amount | $ 911,100 | |||
Secured Debt | Fed Funds Effective Rate Overnight Index Swap Rate | First Lien Initial Term Tranche | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 0.50% | |||
Secured Debt | Eurodollar | First Lien Initial Term Tranche | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 2.25% | |||
Secured Debt | Secured Overnight Financing Rate | First Lien Initial Term Tranche | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 1% | 1% | ||
Secured Debt | Secured Overnight Financing Rate | Maximum | First Lien Initial Term Tranche | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 3.25% | |||
Line of Credit | 2023 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Outstanding borrowings | 56,000 | |||
Deferred debt issuance costs | (3,900) | |||
Remaining borrowing capacity | 426,800 | |||
Covenant terms, ratio of total indebtedness to combined EBITDA | 5 | |||
Covenant terms, ratio of EBITDA to interest expense, net, | 2 | |||
Senior secured credit facilities | ||||
Debt Instrument [Line Items] | ||||
Credit facility, maximum borrowing capacity | $ 750,000 | |||
Senior secured credit facilities | Minimum | ||||
Debt Instrument [Line Items] | ||||
Quarterly amortization | 1,600 | |||
Senior secured credit facilities | Maximum | ||||
Debt Instrument [Line Items] | ||||
Quarterly amortization | $ 3,100 | |||
Senior secured credit facilities | Secured Debt | Fed Funds Effective Rate Overnight Index Swap Rate | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 0.50% | |||
Senior secured credit facilities | Secured Debt | Eurodollar | Minimum | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 1% | |||
Senior secured credit facilities | Secured Debt | Eurodollar | Maximum | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 2.25% | |||
Senior secured credit facilities | Secured Debt | Secured Overnight Financing Rate | Minimum | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 2% | |||
Senior secured credit facilities | Secured Debt | Secured Overnight Financing Rate | Maximum | ||||
Debt Instrument [Line Items] | ||||
Spread on variable rate | 3.25% | |||
Term facility | ||||
Debt Instrument [Line Items] | ||||
Face amount | $ 203,100 | |||
Credit facility, maximum borrowing capacity | 250,000 | |||
Term facility | 2023 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Face amount | $ 243,800 | |||
Interest rate | 8.38% | |||
Deferred debt issuance costs | $ 2,000 | |||
Fair value | 244,100 | |||
Term facility | Short-term debt | ||||
Debt Instrument [Line Items] | ||||
Credit facility, maximum borrowing capacity | 50,000 | |||
Term Facility And Amended Revolver | ||||
Debt Instrument [Line Items] | ||||
Total | $ 1,206,319 | |||
Revolver | ||||
Debt Instrument [Line Items] | ||||
Outstanding borrowings | $ 500,000 | |||
Debt instrument, term | 5 years | |||
Revolver | 2023 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Interest rate | 9.14% | |||
Revolver | Letters of credit | ||||
Debt Instrument [Line Items] | ||||
Credit facility, maximum borrowing capacity | $ 50,000 | |||
Revolver | Line of Credit | Vertex ABL Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Fronting fee | 0.125% | |||
Revolver | Line of Credit | Minimum | 2023 Credit Agreement | Equal To Or Less Than 50% | ||||
Debt Instrument [Line Items] | ||||
Commitment fee percentage | 0.25% | |||
Revolver | Line of Credit | Maximum | 2023 Credit Agreement | Equal To Or Less Than 50% | ||||
Debt Instrument [Line Items] | ||||
Commitment fee percentage | 0.50% |
Debt - Schedule of Maturities (
Debt - Schedule of Maturities (Details) - Term Facility And Amended Revolver $ in Thousands | Mar. 29, 2024 USD ($) |
Payments due | |
2024 (remainder of the year) | $ 11,521 |
2025 | 20,049 |
2026 | 21,611 |
2027 | 21,611 |
2028 | 1,131,527 |
Total | $ 1,206,319 |
Derivative Instruments - Additi
Derivative Instruments - Additional Information (Details) - Cash Flow Hedging - Interest Rate Swap - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Jun. 30, 2023 | Dec. 31, 2023 | |
Derivative [Line Items] | ||||
Derivative contracts entered into during period | $ 350 | |||
Derivative, notional amount | $ 343.8 | $ 345.3 | ||
Designated as hedging instrument | ||||
Derivative [Line Items] | ||||
Gain (loss) on derivative instruments, net, pretax | 1.5 | $ 0 | ||
Gains reclassified to earnings within the next 12 months | $ 4.3 |
Derivative Instruments - Intere
Derivative Instruments - Interest Rate Hedges in the Condensed Consolidated Balance Sheets (Details) - Cash Flow Hedging - Designated as hedging instrument - Interest Rate Swap $ in Thousands | Mar. 29, 2024 USD ($) |
Prepaid expenses and other current assets | |
Derivative [Line Items] | |
Interest rate swap designated as cash flow hedge, liability | $ 4,095 |
Other non-current assets | |
Derivative [Line Items] | |
Interest rate swap designated as cash flow hedge, liability | 1,201 |
Accumulated Other Comprehensive (Loss) Income | |
Derivative [Line Items] | |
Interest rate swap designated as cash flow hedge, liability | $ 5,296 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Dec. 31, 2023 |
Contract compliance | ||
Loss Contingencies [Line Items] | ||
Contracts loss contingency accrual | $ 12.4 | $ 12.1 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Impact of Stock-Based Compensation in Condensed Consolidated Statements of Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation cost for awards | $ 5,149 | $ 12,872 |
Future tax benefit | 1,065 | 2,971 |
Compensation costs for equity-based awards | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation cost for awards | 4,983 | 12,066 |
Compensation costs for liability-based awards | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation cost for awards | $ 166 | $ 806 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | |
Jul. 05, 2022 | Mar. 29, 2024 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Percentage of shareholder return award target | 200% | |
Share-Based Payment Arrangement, Nonemployee | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting period | 1 year | |
Total Shareholder Return Awards (TSR) | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation costs | $ 0.5 | |
Vesting period | 3 years | |
RSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation costs | $ 18.5 | |
Granted (in shares) | 251 | |
Granted (in dollars per share) | $ 44.92 | |
RSUs | Share-Based Payment Arrangement, Employee | Share-based Compensation Award, Tranche One | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting increments | 33.33% | |
RSUs | Share-Based Payment Arrangement, Employee | Share-based Compensation Award, Tranche Two | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting increments | 33.33% | |
RSUs | Share-Based Payment Arrangement, Employee | Share-based Compensation Award, Tranche Three | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting increments | 33.33% | |
PSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation costs | $ 8.1 | |
Granted (in shares) | 96 | |
Granted (in dollars per share) | $ 44.92 | |
Vesting period | 3 years | |
Equity Based Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation costs | $ 26.6 | |
Unrecognized compensation costs, period for recognition | 1 year 10 months 6 days | |
Liability Based Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation costs | $ 0.5 | |
Unrecognized compensation costs, period for recognition | 9 months 3 days |
Stock-Based Compensation - Sc_2
Stock-Based Compensation - Schedule of Non-Qualified Stock Options, Activity (Details) shares in Thousands | 3 Months Ended |
Mar. 29, 2024 $ / shares shares | |
NQOs | |
NQOs, Shares | |
Outstanding at beginning of period (in shares) | shares | 40 |
Outstanding at end of period (in shares) | shares | 40 |
NQOs, Weighted Average Exercise Price Per Share | |
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 22.93 |
Outstanding at end of period (in dollars per share) | $ / shares | $ 22.93 |
RSUs | |
NQOs, Shares | |
Exercised (in shares) | shares | (397) |
Exercised (in dollars per share) | $ / shares | $ 42.15 |
RSUs, Shares | |
Outstanding at beginning of period (in shares) | shares | 800 |
Granted (in shares) | shares | 251 |
Forfeited or expired (in shares) | shares | (29) |
Outstanding at end of period (in shares) | shares | 625 |
RSUs, Weighted Average Grant Date Fair Value | |
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 37.29 |
Granted (in dollars per share) | $ / shares | 44.92 |
Forfeited or expired (in dollars per share) | $ / shares | 39.83 |
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 40.86 |
PSUs | |
RSUs, Shares | |
Outstanding at beginning of period (in shares) | shares | 267 |
Granted (in shares) | shares | 96 |
Forfeited or expired (in shares) | shares | (34) |
Outstanding at end of period (in shares) | shares | 329 |
RSUs, Weighted Average Grant Date Fair Value | |
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 43.45 |
Granted (in dollars per share) | $ / shares | 44.92 |
Forfeited or expired (in dollars per share) | $ / shares | 39.45 |
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 41.88 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |||
Income tax benefit | $ 20 | $ 5,737 | |
Effective income tax rate | (1.80%) | 24.70% | |
Unrecognized tax benefits | $ 6,600 | $ 6,600 |
Earnings Per Share - Reconcilia
Earnings Per Share - Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Earnings Per Share [Abstract] | ||
Net income (loss) | $ 1,144 | $ (17,480) |
Weighted average common shares outstanding (in shares) | 31,351 | 30,927 |
Add: Dilutive impact of stock options (in shares) | 18 | 0 |
Add: Dilutive impact of restricted stock units (in shares) | 425 | 0 |
Diluted weighted average common shares outstanding (in shares) | 31,794 | 30,927 |
Earnings (loss) per share | ||
Basic (in dollars per share) | $ 0.04 | $ (0.57) |
Diluted (in dollars per share) | $ 0.04 | $ (0.57) |
Earnings Per Share - Anti-dilut
Earnings Per Share - Anti-dilutive Options (Details) - shares shares in Thousands | 3 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive stock options (in shares) | 25 | 0 |
Anti-dilutive stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive stock options (in shares) | 0 | 0 |
Anti-dilutive restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive stock options (in shares) | 25 | 0 |
Post-Employment Benefit Plans (
Post-Employment Benefit Plans (Details) $ in Millions | 3 Months Ended | ||
Mar. 29, 2024 USD ($) plan | Mar. 31, 2023 USD ($) | Dec. 31, 2023 USD ($) | |
Retirement Benefits [Abstract] | |||
Number of compensation plans | plan | 2 | ||
Plan assets and liabilities | $ 4.2 | $ 3.2 | |
Expense recognized | $ 5 | $ 3.3 |
Sale of Receivables - Schedule
Sale of Receivables - Schedule of Receivables Sold (Details) $ in Thousands | 3 Months Ended |
Mar. 29, 2024 USD ($) | |
Transfers of Financial Assets Accounted For As Sale [Roll Forward] | |
Beginning balance | $ 72,715 |
Sale of receivables | 621,920 |
Cash collections | (588,266) |
Outstanding balance sold to MUFG | 106,369 |
Cash collected, not remitted to MUFG | (24,167) |
Remaining sold receivables | 82,202 |
Collections from operating activities | $ 33,700 |
Sale of Receivables (Details)
Sale of Receivables (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 29, 2024 | Dec. 31, 2023 | Sep. 28, 2023 | |
Receivables [Abstract] | |||
Availability under receivables purchase agreement | $ 82,202 | $ 72,715 | $ 200,000 |
Purchase discount fees | $ 1,600 |